Programming – Vascular Discovery 2024
May 15–18, 2024
Hilton Chicago | Chicago, Illinois
Vascular Discovery 2024 Schedule-at-a-Glance
All times are Central Daylight Time (CDT, GMT -5)
| Time | Activity |
|---|---|
| 8:00 a.m. to 6:00 p.m. | Vascular Research Initiatives Conference(link opens in new window) This event is not part of the official Vascular Discovery Scientific Sessions as planned by the Program Committee. Separate registration is required to attend. |
| 3:00 p.m. to 7:00 p.m. | Vascular Discovery Scientific Sessions Registration |
| 6:30 p.m. to 8:00 p.m. | Poster Session 1 & Reception |
| Time | Activity |
|---|---|
| 7:00 a.m. to 6:00 p.m. | Registration, Exhibits |
| 7:00 a.m. to 8:00 a.m. | Morning Coffee |
| 7:00 a.m. to 8:00 a.m. | Early Career Training Session 1 – Academic Roundtables 7:00 - Getting Your Training Grant Funded 7:00 - Saying No and Difficult Conversations 7:00 - Setting Up Your Lab, Hiring and Switching Universities 7:00 - The Importance of Mentoring and Being Mentored 7:00 - Work-Life Balance 7:00 - Strategies for Project Management |
| 8:00 a.m. to 8:30 a.m. |
Conference Opening Welcome 8:00 Welcome Remarks from AHA President 8:15 Welcome Remarks from the Program Chair |
| 8:30 a.m. to 10:00 a.m. |
Plenary Session 1: Hot Topics in Cardiovascular Disease 8:30 Complementing Human Organoids for Vascular Discovery 9:00 Clonal hematopoiesis, aging, and CVD 9:30 Functional Multiomics to Identify Genetic Mechanisms Underlying Atherosclerosis |
| 10:00 a.m. to 10:30 a.m. | BREAK/Exhibits |
| 10:30 a.m. to 12:15 p.m. |
Concurrent Session 1a: Molecular and Cellular Mechanisms of Atherosclerosis 10:30 Title TBA 11:00 100 - Omics Strategies To Identify Senescent Cells Mediating Extracellular Matrix Remodeling During Vascular Disease 11:15 101 – The Smooth Muscle-specific Long Non-coding RNACarmnIs Critical For Maintaining Vascular Smooth Muscle Contractility 11:30 102 - Trained Immunity Impairs Inflammation Resolution And Dampens Efferocytosis 11:45 103 - Acly Inhibition As A Novel Therapeutic Approach For Vascular Remodeling In Coronary Artery Disease 12:00 104 - Endothelial Restoration Of CAD GWAS Gene PLPP3 By Nanomedicine Suppresses Mechano-sensitive YAP/TAZ Activity And Reduces Atherosclerosis In Vivo |
| 10:30 a.m. to 12:15 p.m. |
Concurrent Session 1b: Inflammation & Immunity in the Vessel Wall 10:30 Macrophages in Aortic Aneurysm 11:00 105 - Neutrophil Cracr2a Is Crucial For Calcium Signaling And Enhances Neutrophil Adhesive Function Under Thromboinflammatory Conditions 11:15 106 - Cd40 Is Required For B1b Cell Homeostasis In Atherosclerosis 11:30 107 - Effects Of Immune-checkpoint Inhibitors On Atherosclerosis In Halted Progression Model 11:45 108 - Inflammasome Activation Via BRCC3-mediated NLRP3 Deubiquitylation Promotes Atherosclerosis In Tet2 Clonal Hematopoiesis 12:00 109 - Estrogen Receptor Alpha Inhibition Of Mineralocorticoid Receptor In Endothelial Cells As A Mechanism Of Protection From Atherosclerosis Inflammation |
| 10:30 a.m. to 12:15 p.m. |
Concurrent Session 1c: Endothelial Dysfunction in Thrombosis 10:30 Regulation of Endothelial Procoagulant Activity by TMEM16 Proteins 10:50 Genetic analysis of endothelial protease-activated receptors in disease contexts 11:10 Presentation Title: TBD 11:30 110 - Pro-thrombotic BCR-ABL Tyrosine Kinase Inhibitors Ponatinib And Nilotinib, But Not The Novel Agent Asciminb, Impair Endothelial Cell Wound Healing 11:41 111- COL8A1 Modulates Endothelial Phenotype During Inflammatory Endothelial-to-Mesenchymal Transition 11:52 112 - Endothelial Mixed Lineage Leukemia 1 (kmt2a/MLL1) As A Central Mediator Of Immunothrombosis During SARS-CoV-2 Infection 12:03 113 - Endothelial Argonaute 1: A Novel Regulator Of Hyperlipidemia And Atherosclerosis |
| 12:15 p.m. to 2:00 p.m. | The Mentor of Women Award Luncheon - Presented by the ATVB Women's Leadership Committee (ticket required) 12:15 - Networking 12:30 - Thriving as Internationally Trained Scholars
1:10 - Round Table Discussions
1:50 - Networking or or |
| 2:15 p.m. to 3:45 p.m. | Plenary Session 2: Highlights from the ATVB Journal Moderators: Yabing Chen, PhD, Hong Lu, MD, PhD, and Ravichandran Ramasay, PhD 2:15 - ATVB Journal Update 2:30 - Daniel Steinberg Early Career Investigator Award in Atherosclerosis/Lipoproteins: Peripheral Ischemia Imprints Epigenetic Changes in Hematopoietic Stem Cells to Propagate Inflammation and Atherosclerosis 2:45 - Karl Link Early Career Investigator Award in Thrombosis: Antithrombin, Protein C, and Protein S: Genome and Transcriptome-Wide Association Studies Identify 7 Novel Loci Regulating Plasma Levels 3:00 - Werner Risau Early Career Investigator Award in Vascular Biology: Dedifferentiation and Proliferation of Artery Endothelial Cells Drive Coronary Collateral Development in Mice 3:15 - Presentation Title: TBA |
| 3:45 p.m. to 4:15 p.m. | Break/Exhibits |
| 4:15 p.m. to 6:00 p.m. |
Concurrent Session 2a: Apolipoproteins, Lipoproteins, and Lipid Metabolism 4:15 Massively Parallel Interrogation of Lipoprotein Uptake Modifiers 4:45 114 - Inhibition Of Lecithin Cholesterol Acyl Transferase By A Novel Anti-apolipoprotein A1 Antibody Fragment 5:00 115 - Scavenger Receptor-BI Mediates Endothelial Uptake Of Lipoprotein(a) 5:15 116 - Apolipoprotein E Registry In Discoidal Lipoproteins Influences Uptake 5:30 117 - AIBP Deficiency Affects Inflammarafts Formation And Macrophage Reprogramming In Atherosclerosis 5:45 118 - Dennd5b Affects Dietary Lipid Absorption And Metabolism In Male And Female Mice |
| 4:15 p.m. to 6:00 p.m. |
Concurrent Session 2b: Thrombosis: Signaling, Mechanisms and Function 4:15 Targeting Neutrophils in Immunothrombosis 4:45 119 - LRRC8 Complex Is An ATP Release Channel Regulating Platelet Activation And Thrombosis 5:00 120 - Neutrophilic Mice Are Protected Against Staphylococcus Aureus Sepsis And Immunothrombosis Through Peptidylarginine Deiminase 4-mediated Neutrophil Extracellular Trap Formation 5:15 121 - Ponatinib Promotes Endothelial Cell Inflammation And Leukocyte Trafficking Via Tumor Necrosis Factor Signaling: A Potential Mechanism Of Vascular Toxicity 5:30 122 - Deletion Of Pyruvate Dehydrogenase Kinases Reduces Susceptibility To Experimental Venous Thrombosis By Limiting Glycolysis In Neutrophils 5:45 123 - Hemostatic Fibrin Knob Triggered Microgel To Promote Clotting With Reduced Thrombotic Risks In Neonates |
| 4:15 p.m. to 6:00 p.m. |
Concurrent Session 2c: Investigator in Training Award Oral Abstract Competition 4:15 124 - IRG1-Itaconate Axis Protects From Cholesterol-Induced Inflammation And Atherosclerosis 4:30 125 - The X Chromosome Gene Kdm6a Confers Sex Differences In Mature Adipocyte Function Impacting Cardiometabolic Health 4:45 126 - Reduction Of Abdominal Aortic Aneurysm Rupture By Modulating Smooth Muscle Cell Phenotype Switching 5:00 127 - Pushing The Limits Of Macrophage Efferocytosis In Atherosclerosis 5:15 128 - Blood TMAO Predicts Abdominal Aortic Aneurysm Growth Rate And Need For Surgical Intervention 5:26 129 - Hypercholesterolemia-induced Lxr Signaling In Smc Contributes To Atherosclerotic Lesion Remodeling And Regulates Vascular And Visceral Smc Function 5:37 130 - Cftr Is Essential For Endothelium-dependent Vasorelaxation 5:48 162 - Post-transcriptional Regulation Of FGF21 In Obesity And Metabolism |
| 6:00 p.m to 7:30 p.m. |
Poster Session 2 & Reception |
| Time | Activity |
|---|---|
| 7:00 a.m. to 6:00 p.m. | Registration and Exhibits |
| 7:00 a.m. to 8:00 a.m. | Morning Coffee |
| 7:00 a.m. to 8:00 a.m. | Early Career Training Session 2 – Academic Success Stories (Panel Discussion) 7:00 - Panel Discussants |
| 8:00 a.m. to 9:30 a.m. |
Plenary Session 3: Advances in Cardiometabolic Disease 8:00 Presentation title TBA 8:30 16 Years of GWAS - From a Single Locus to 393 Genome-wide Significant CAD Associations 9:00 Gut Bacterial Metabolism and Cardiometabolic Disease |
| 9:30 a.m. to 10:00 a.m. | BREAK/Exhibits |
| 10:00 a.m. to 11:45 a.m. |
Concurrent Session 3a: Therapeutic Targets in Atherosclerosis 10:00 Enhanced endothelial cell retention within tissue engineered vascular grafts 10:30 131 - Local Pcsk6 Inhibition Attenuates VSMC Response In Vascular Injury And Restenosis 10:45 132 - Immunosenescence-related Biomarkers And Potential Therapeutic Targets For Coronary Artery Disease Identified Via Plasma Proteome And Immune Cell Traits 11:00 133 - Trem2 Agonist Promotes Atherosclerotic Plaque Stability 11:15 134 - Lesion-specific Suppression Of YAP/TAZ By Biomimetic Nanoparticles Ameliorates Atherosclerosis 11:30 135 - Monocytes Reprogrammed By 4-PBA Potently Contribute To The Resolution Of Inflammation And Atherosclerosis |
| 10:00 a.m. to 11:45 a.m. |
Concurrent Session 3b: Blood Coagulation in Health & Disease 10:00 Presentation title TBA 10:30 136 - Protease-activating Receptor-4 Antagonism In Coronary Artery Disease 10:45 137 - Identification Of A Noncoding Genetic Variant In The Tissue Factor Locus That Reverses Lethal Thrombosis In Mice 11:00 138 - Platelet RIPK1 Promotes Platelet Activation And Aggregation In Arteriolar Thrombosis And Ischemic Stroke 11:15 139 - Contribution Of Platelet Granule Cargo Uptake And Secretion To The Initiation And Progression Of Aortic Aneurysms 11:30 140 - Exploring Protein Kinase C Theta (PKCΘ) Signaling In The Generation Of Procoagulant Platelet: Insights From Phosphoproteomics And Systems Analysis |
| 10:00 a.m. to 11:45 a.m. |
Concurrent Session 3c: Translational Studies in Non-Coronary Vascular Disease 10:00 Presentation title TBA 10:20 Presentation title TBA 10:40 Exploring Carotid Plaque Instability: a BIKE-ride from Identification of Molecular Disease Targets to Improved Stroke-risk Prediction 11:00 Endothelial Dysfunction in Carotid Atherothrombosis and Stroke 11:20 141 - Lesion Site-specific Mass Spectrometry Analysis Of Human Carotid Plaques Reveals Strongest Association Of The Necrotic Core And Fibrous Cap Proteome With Plaque Stability 11:32 142 - Nr3c1-Sfrp1 Axis Regulates The Adipogenic Differentiation Of Vcam1+ Fibro-adipogenic Progenitors In Chronic Limb Threatening Ischemia |
| 11:45 a.m. to 12:45 p.m. | Building Inclusive Mentoring Relationships Presented by the ATVB Diversity Committee |
| 11:45 a.m. to 1:45 p.m. | Lunch on your own |
| 1:45 p.m. to 3:45 p.m. | Plenary Session 4: Early Career Investigator Award Competition: Brinkhous Prize and Page Jr Faculty Research Award Moderators: Milka Koupenova, PhD, Sidney Whiteheart, PhD, Nick Leeper, MD, and Wayne Orr, PhD 1:45 153 - Multi-parametric Thrombus Profiling Microfluidics Uncovers Mechanobiology Of Hypertension And Aging-related Thrombosis 2:00 154 - Hierarchical Redundancy And Contextual Roles Of Vesicle-associated Membrane Proteins (VAMPs) In Platelet Function 2:15 155 - Plasma Kallikrein Is A Key Driver Of Basal Activation Of Coagulation Under Conditions Of C1 Inhibitor Deficiency 2:30 156 - Pyruvate Kinase M2 Regulates SNAP23-mediated Platelet Granule Exocytosis, Neutrophil Extracellular Traps Formation And Experimental Venous Thrombosis 2:45 157 - Atherosclerosis Is A Smooth Muscle Cell-driven Tumor-like Disease 3:00 158 - The Role Of Ehbp1 In Hypercholesterolemia 3:15 159 - Endothelial Fatty Acid-binding Proteins Contribute To The Pathogenesis Of Pulmonary Hypertension 3:30 160 - Macrophage-specific Ablation Of Bmal1 Regulates Cholesterol Transport And Enhances Atherosclerosis |
| 3:45 p.m. to 4:15 p.m. | Break/Exhibits |
| 4:15 p.m to 6:00 p.m. |
Concurrent Session 4a: Metabolic Disorders in Atherosclerosis 4:15 Unlocking the Potential of Microbial-Host-Isozyme for Precision Treatment of Metabolic Diseases 4:45 Comprehensive Management of Metaboic Vascular Disease - 20 Years Vascular Health Promotion in China 5:15 Deubiquitinase BRCC3 Orchestra Metabolic Remodeling in Cardiovascular Disease 5:30 Prevention of Cardiovascular Disease: the Traditional Chinese Medicine Strategy 5:45 143 - Multi-omics Integration From A Large Human Biobank Identifies Key Molecular Mechanisms And Signatures Of Atherosclerotic Plaque Instability 5:50 144 - Pyruvate Dehydrogenase Kinase 4 Contributes To Abdominal Aortic Aneurysm Through Accelerating Smooth Muscle Cell Metabolic Reprogramming And Nlrp3 Inflammasome-dependent Pyroptosis |
| 4:15 p.m to 6:00 p.m. |
Concurrent Session 4b: Vascular Cells, Inflammation and Thrombosis 4:15 Cardiovascular Calcification 4:45 145 - Chronic Electronic Cigarette Exposure Accelerates SMC Phenotypic Modulation And Activates The NMDA-type Glutamate Receptor (NMDAR) Pathway In Mediating Vascular Calcification 5:00 146 - Phosphodiesterase 10A Mediates Arterial Calcification Through A P38/MAPK-MMP3 Signaling 5:15 147 - Monocyte-derived Extracellular Delta-like 4 Contributes To Pulmonary Hypertension Progression By Inhibiting Endothelial Notch1 Activation 5:30 148 - Loss Of Tlr4 Signaling Inhibits Thrombus Resolution In A Non-monocyte Dependent Manner 5:45 149 - The Protective Effect Of Vamp8 Deficiency In Aortopathies: Potential Impact Of Impaired Platelet Cargo Release |
| 4:15 p.m to 6:00 p.m. |
Concurrent Session 4c: Genomics and Multi-Omics in Vascular Disease 4:15 Presentation Title TBA 4:45 Presentation Title TBA 5:15 150 - Decoding The Variant-to-function Relationship For LIPA, A Risk Locus For Cad 5:30 151 - Single Cell Transcriptional And Epigenetic Map Of Human Coronary Artery Disease In A Multi-ethnic Population 5:45 152 - Osteochondrogenic Transcription Factor SOX9 Regulates The Epigenetic Mechanisms Of Atherosclerosis And Intimal Calcification |
| 6:00 p.m. to 7:30 p.m. |
Poster Session 3 and Reception |
| 7:30 p.m. to 10:00 p.m. |
Joint Council Dinner
|
| Time | Activity |
|---|---|
| 7:00 a.m. to 12:00 p.m. | Registration |
| 7:00 a.m. to 8:30 a.m. | Morning Coffee |
| 8:30 a.m. to 10:00 a.m. |
Plenary Session 5: Cardio-oncology: The Role of the Vasculature 8:30 Cardio-oncology Through a Vascular Lens 9:00 Racial Disparities in Cardio-oncology - Defining Differences in Endothelial Function in Response to Anti-Cancer Therapy 9:30 Presentation title TBA 9:45 161 - Myocardial Infarction Accelerates Melanoma Tumor Progression |
| 10:00 a.m. to 10:15 a.m. | BREAK/Exhibits |
| 10:15 a.m. to 12:15 p.m. |
Plenary Session 6: Invited Lecture Series 10:15 Hoeg Award Lecture 10:45 Keynote Lecture 11:15 Distinguished Lecture: Targets for New Anticoagulants: XI Before XII 11:45 PVD Mid-Career Award Lecture |
| 12:15 p.m. | Closing Remarks / Adjourn |
Keynote Lecture and Distinguished Lecture Speakers
Kristy Red-Horse, PhD
Invited Lecture Series
Presentation Title: TBD
Kristy Red-Horse is a Professor at Stanford University’s Department of Biology and Institute for Stem Cell Biology & Regenerative Medicine. She is also an Investigator with the Howard Hughes Medical Institute. Her PhD research explored how the vasculature of the placenta incorporates within the uterine arterial network. As a postdoc at Stanford, Dr. Red-Horse identified the progenitors of coronary arteries in mouse hearts. In her own lab, she and her team went on to explore many different aspects of how coronary arteries develop from these progenitors. The Red-Horse group also studies how coronaries regenerate and respond to injury, and devises methods for increasing their growth to enhance cardiac recovery. Dr. Red-Horse has received awards such as the NIH Pathway to Independence Award (K99/R00) and the Searle Scholar’s Award. She was also a New York Stem Cell Foundation—Robertson Investigator and received the Judah Folkman Award in vascular biology. In 2021, Dr. Red-Horse was named a Howard Hughes Investigator. In 2023, Dr. Red-Horse became a member of the National Academy of Medicine.
Jeffrey Weitz, MD, FAHA, FRCPC, FRSC, FACP
Invited Lecture Series
Presentation Title: Targets for new anticoagulants: XI before XII
Dr. Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University, Executive Director of the Thrombosis and Atherosclerosis Research Institute and Past President of Council for the International Society on Thrombosis and Haemostasis. Board Certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Weitz focuses his clinical practice on patients with thrombotic disorders. His research spans the spectrum from basic studies in the biochemistry of blood coagulation and fibrinolysis to animal models of thrombosis and on to clinical trials of antithrombotic therapy. The breadth of his work is highlighted by his over 640 publications in journals as diverse as the Journal of Clinical Investigation, Journal of Biological Chemistry, Biochemistry, Circulation, Blood, Annals of Internal Medicine, New England Journal of Medicine and Lancet, and 76 book chapters. The recipient of numerous awards, Dr. Weitz was appointed as an Officer of the Order of Canada and is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences.
Chiara Giannarelli, MD, PhD
Hoeg Award Lecture
Presentation Title: TBA
Chiara Giannarelli, MD, PhD, is an Associate Professor of Medicine and Pathology at the Department of Medicine, Division of Cardiology, and Cardiovascular Research Center at NYU Langone NYU Grossman School of Medicine, New York. She completed her medical degree and subsequent residency and clinical fellowship before pursuing a PhD in pharmacological sciences and pathophysiological mechanisms of cardiovascular disease at the University of Pisa, Italy. In 2008, she relocated to the USA, where she conducted a research fellowship at the Icahn School of Medicine at Mount Sinai, eventually being appointed Assistant Professor in 2014. Joining NYU in 2021, Dr. Giannarelli's research integrates systems pharmacology and systems immunology with molecular biology and imaging to uncover novel mechanisms underlying cardiovascular disease. A groundbreaking accomplishment of her laboratory was the pioneering use of single-cell proteomic and transcriptomic analyses (CyTOF, CITE-seq, scRNA-seq) of human vascular samples, recognized as a significant milestone in inflammation research in atherosclerosis (Nature Medicine, 2019). Dr. Giannarelli has leveraged systems immunology and drug repositioning approaches to identify new compounds targeting the innate immune system in atherosclerosis, mitigating plaque inflammation (Nature Cardiovascular Research, June 2023). Her work has also explored how SARS-CoV-2 infection triggers proatherogenic immune responses in the human vasculature (Nature Cardiovascular Research, October 2023). Continuously funded by the NIH/NHLBI, NIH/NCATS, and prestigious programs such as the American Heart Association Strategically-Focused Research Networks, Chan-Zuckerberg Foundation, and PolyBio Foundation, Dr. Giannarelli's expertise in translational systems immunology and drug repurposing approaches has made her a vital contributor to large multiple-PI programs.
Scott M. Damrauer, MD, FAHA
PVD Mid-Career Award Lecture
Presentation Title: TBD
Dr. Scott Damrauer is a surgeon-scientist dedicated to advancing the understanding of the biological pathways and mechanisms most relevant in the etiology, progression and treatment of heart and vascular disease. His research leverages his clinical vascular surgery experience to inform population-scale genomic research. In this, he has focused primarily on peripheral artery disease (PAD), venous thromboembolism (VTE), abdominal aortic aneurysm (AAA) and thoracic aortic disease (TAD). As part of the VA Million Veteran Program and the Penn Medicine BioBank, Dr. Damrauer’s work has significantly advanced our understanding of the genetic architecture of these diseases. He’s currently exploring the causal relationship of risk factors across traits, identifying novel therapeutic targets, and developing new ways to use genetics to identify people at risk.
Genomic medicine has been criticized for the lack of studies in diverse populations. To address these disparities, Dr. Damrauer has led a large interagency collaboration between the VA and the Department of Energy to map the genetic architecture of health and disease traits in more than 650,00 diverse veterans as part of the VA Million Veteran Program. These analyses represent the largest existing effort to understand the genetics of health and disease in diverse populations in the United States.
Dr. Damrauer’s work is supported by the NIH and the VA Office of Research and Development.
Vascular Discovery 2024
Invited Speakers
Carl Ade, PhD
Session: Cardio-oncology: the Role of the VasculaturePresentation Title: TBD
Zoltan Arany, MD, PhD
Session: Advances in Cardiometabolic DiseasePresentation Title: TBD
Andreas Beyer, PhD
Session: Cardio-oncology – The Role of the VasculaturePresentation Title: Racial disparities in cardio-oncology – Defining Differences in Endothelial Function in Response to Anti-Cancer Therapy
Nirav Dhanesha, PhD
Session: Blood Coagulation in Health and DiseasePresentation Title: TBA
Brian Emmer MD, PhD
Session: Apolipoproteins, Lipoproteins and Lipid MetabolismPresentation Title: Massively Parallel Interrogation of Lipoprotein Uptake Modifiers
Santhi Ganesh, MD
Session: Translational Studies in Non-Coronary Vascular DiseasePresentation Title: TBD
Courtney Griffin, PhD
Session: Endothelial Dysfunction in ThrombosisPresentation Title: Genetic analysis of endothelial protease-activated receptors in disease contexts
Kaizheng Gong, MD, PhD
Session: Metabolic Disorders in Atherosclerosis - Organized in Cooperation with the Chinese International Congress of Vascular MedicinePresentation Title: Deubiquitinase BRCC3 Orchestra Metabolic Remodeling in Cardiovascular Disease
Ulf Hedin, MD, PhD
Session: Translational Studies in Non-Coronary Vascular DiseasePresentation Title: Exploring carotid plaque instability: a BiKE-ride from identification of molecular disease targets to improved stroke-risk prediction
Kathryn L Howe MD, PhD, FRCSC
Session: Translational Studies in Non-Coronary Vascular DiseasePresentation Title: Endothelial Dysfunction in Carotid Atherothrombosis and Stroke
Iris Jaffe, MD, PhD
Session: Cardio-oncology the Role of the VasculaturePresentation Title: Cardio-oncology Through a Vascular Lens
Changtao Jiang, MD, PhD
Session: Metabolic Disorders in Atherosclerosis - Organized in Cooperation with the Chinese International Congress of Vascular MedicinePresentation Title: Unlocking the Potential of Microbial-Host-Isozyme for Precision Treatment of Metabolic Diseases
Minna Kaikkonen, PhD
Session: Hot Topics in Cardiovascular DiseasePresentation Title: Functional Multiomics to Identify Genetic Mechanisms Underlying Atherosclerosis
Bo Liu, PhD
Session: Inflammation & Immunity in the Vessel WallPresentation Title: Macrophages in Aortic Aneurysm
Ruth McPherson, MD, PhD, FRCPC
Session: Advances in Cardiometabolic DiseasePresentation Title: 16 years of GWAS – From a Single Locus to 393 Genome-wide Significant CAD Associations
Clint Miller, PhD
Session: Genomics and Multi-Omics in Vascular DiseasePresentation Title: TBD
Lalitha Nayak, MD
Session: Thrombosis, Signaling Mechanisms, & FunctionPresentation Title: Targeting Neutrophils in Immunothrombosis
Hasina Outtz Reed, MD, PhD
Session: Endothelial Dysfunction in ThrombosisPresentation Title: TBD
Muredach Reilly, MD
Session: Molecular and Cellular Mechanisms of AtherosclerosisPresentation Title: TBD
Federico E. Rey, PhD
Session: Advances in Cardiometabolic DiseasePresentation Title: Gut Bacterial Metabolism and Cardiometabolic Disease
Alec A. Schmaier, MD, PhD
Session: Endothelial Dysfunction in ThrombosisPresentation Title: Regulation of endothelial procoagulant activity by TMEM16 proteins
Cynthia St. Hilaire, PhD, FAHA
Session: Vascular Cells, Inflammation and ThrombosisPresentation Title: Cardiovascular Calcification
Takanori, Takebe, MD, PhD
Session: Hot Topics in Cardiovascular DiseasePresentation Title: Complementing Human Organoids for Vascular Discovery
Catherine Tcheandjieu, DVM, PhD
Session: Genomics and Multi-Omics in Vascular DiseasePresentation Title: TBD
Brandon Tefft, PhD
Session: Therapeutic Targets in AtherosclerosisPresentation Title: Enhanced endothelial cell retention within tissue engineered vascular grafts
Kenneth Walsh, PhD
Session: Hot Topics in Cardiovascular DiseasePresentation Title: Clonal Hematopoiesis, Aging, and CVD
Hongyu Wang, MD, PhD
Session: Metabolic Disorders in Atherosclerosis - Organized in Cooperation with the Chinese International Congress of Vascular MedicinePresentation Title: Comprehensive Management of Metabolic Vascular Disease: 20 Years Vascular Health Promotion in China
Chaoping Yu, MD
Session: Metabolic Disorders in AtherosclerosisPresentation Title: Prevention of Cardiovascular Disease: the Traditional Chinese Medicine Strategy
Wei Zhou, MD
Session: Translational Studies in Non-Coronary Vascular DiseasePresentation Title: TBD
About this Meeting
This 2 ½-day meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology, the Peripheral Vascular Disease Council, and the Council on Genomic and Precision Medicine, in cooperation with and the Society for Vascular Surgery's Vascular Research Initiatives Conference.
Vascular Discovery 2024 will provide unique opportunities to meet with colleagues from around the world with wide-ranging research interests and expertise for the timely exchange of information about new and emerging scientific research in the areas of arteriosclerosis, thrombosis and vascular biology, peripheral vascular disease, vascular surgery research, genomics and precision medicine. We expect a broad representation from many disciplines and encourage young scientists to attend.
See the American Heart Association Policies and Guiding Values (PDF).
Target Audience
The conference will especially appeal to scientists and clinicians interested in:
- Allergy and Immunology
- Arteriosclerosis
- Biochemistry
- Biological Sciences
- Diabetes and Metabolism
- Functional Genomics
- Genetics
- Hematology
- Internal Medicine
- Molecular/Cellular Biology
- Nutrition
- Pathology
- Peripheral Artery Disease
- Pharmacology
- Physiology
- Vascular Surgery
- Thrombosis
- Vascular Biology
- Vascular Medicine
Learning Objectives
At the conclusion of this conference, participants will be able to:
- Discuss recent advances and emerging experimental models in ATVB and peripheral vascular diseases that target primary acquired diseases and/or secondary factors contributing to vascular-related disorders.
- Summarize findings from recent translational research or clinical trials and the impact for future treatment and/or management of vascular-related disorders.
- Describe best practices associated with ATVB scientific research and/or the management of patients with vascular-related diseases.